Skip to main content
. 2022 Nov 23;14(23):5756. doi: 10.3390/cancers14235756

Table A3.

Comparisons between characteristics of patients with lung cancer at time of diagnosis, by late vs. early stage.

All (n = 711) Early Stage (n = 238) Late Stage (n = 385) p Value
Age (years) 18–49 36 (5.1%) 9 (3.8%) 23 (6.0%) 0.5478
50–59 129 (18.1%) 37 (15.5%) 72 (18.7%)
60–69 261 (36.7%) 90 (37.8%) 141 (36.6%)
70–79 185 (26.0%) 66 (27.7%) 100 (26.0%)
80+ 100 (14.1%) 36 (15.1%) 49 (12.7%)
Sex Female 356 (50.1%) 136 (57.1%) 179 (46.5%) 0.0124
Male 355 (49.9%) 102 (42.9%) 206 (53.5%)
Race/Ethnicity Asian or Pacific Islander 80 (11.3%) 25 (10.5%) 44 (11.4%) 0.9514
Hispanic or Latino 23 (3.2%) 9 (3.8%) 12 (3.1%)
Non-Hispanic Black 68 (9.6%) 26 (10.9%) 39 (10.1%)
Non-Hispanic White 524 (73.7%) 174 (73.1%) 281 (73.0%)
Other 16 (2.3%) 4 (1.7%) 9 (2.3%)
Smoking status Current or former 531 (74.7%) 191 (80.3%) 278 (72.2%) 0.0015
Never 122 (17.2%) 42 (17.6%) 71 (18.4%)
No data 58 (8.2%) 5 (2.1%) 36 (9.4%)
Insurance No insurance or Unknown 14 (2.0%) 2 (0.8%) 9 (2.3%) 0.2257
Private Insurance 130 (18.3%) 38 (16.0%) 73 (19.0%)
Public Insurance 567 (79.7%) 198 (83.2%) 303 (78.7%)
Census Tract Poverty Indicator 0–<10% poverty 383 (53.9%) 129 (54.2%) 207 (53.8%) 0.5021
10–<20% poverty 222 (31.2%) 68 (28.6%) 123 (31.9%)
≥20–100% poverty 106 (14.9%) 41 (17.2%) 55 (14.3%)
Comorbidity—Elixhauser van Walraven Weighted Score Mean (SD) 17.4 (11.8) 13.9 (10.2) 19.8 (12.2) <0.0001